Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.85 is 48% above its 5-year average of 1.93, near the high end of its 5-year range (0.64–3.40).
As of the fiscal period ended Tuesday, June 30, 2026. 24.51% above its 12-month average of 2.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.85.
QUICK RATIO (ACID-TEST)
2.85
QUICK RATIO (ACID-TEST) AVG TTM
2.29
QUICK RATIO (ACID-TEST) AVG 3Y
2.08
QUICK RATIO (ACID-TEST) AVG 5Y
1.93
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.51%
CURRENT VS 3Y AVG
+37.24%
CURRENT VS 5Y AVG
+47.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-15.08%
vs the sector median at left
Biodesix, Inc.
Market Cap
$227.60M
Quick Ratio (Acid-Test)
2.85
TTM Avg
2.29
3Y Avg
2.08
5Y Avg
1.93
Market Cap
$225.24M
Quick Ratio (Acid-Test)
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
Market Cap
$231.37M
Quick Ratio (Acid-Test)
2.96
TTM Avg
4.42
3Y Avg
4.46
5Y Avg
4.62
Market Cap
$231.77M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$220.93M
Quick Ratio (Acid-Test)
5.31
TTM Avg
10.41
3Y Avg
9.80
5Y Avg
12.54
Market Cap
$235.08M
Quick Ratio (Acid-Test)
44.27
TTM Avg
28.93
3Y Avg
23.00
5Y Avg
20.76
Market Cap
$235.66M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.13
3Y Avg
1.14
5Y Avg
1.18
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biodesix, Inc. (BDSX) | $227.60M | 2.85 | 2.29 | 2.08 | 1.93 |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.24M | 10.14 | 15.36 | 19.42 | 27.25 |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | 2.96 | 4.42 | 4.46 | 4.62 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | 1.54 | 1.17 | 19.33 | 29.22 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.35 | 5.50 | 5.94 |
| Profound Medical Corp. (PROF)vs › | $220.93M | 5.31 | 10.41 | 9.80 | 12.54 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 44.27 | 28.93 | 23.00 | 20.76 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.35 | 1.13 | 1.14 | 1.18 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 16.48 | 8.13 | 6.57 | 7.38 |
Quick Ratio
2.85
Excludes inventory
Current Ratio
2.85
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.85 |
| 2026-03-31 | 2.82 |
| 2025-12-31 | 1.86 |
| 2025-09-30 | 1.76 |
| 2025-06-30 | 2.14 |
| 2025-03-31 | 2.22 |
| 2024-12-31 | 2.76 |
| 2024-09-30 | 3.40 |
| 2024-06-30 | 3.28 |
| 2024-03-31 | 0.91 |
| 2023-12-31 | 1.19 |
| 2023-09-30 | 0.88 |
| 2023-06-30 | 0.90 |
| 2023-03-31 | 1.57 |
| 2022-12-31 | 2.34 |
| 2022-09-30 | 0.64 |
| 2022-06-30 | 1.06 |
| 2022-03-31 | 0.91 |
| 2021-12-31 | 1.51 |
| 2021-09-30 | 2.36 |
| 2021-06-30 | 3.07 |
| 2021-03-31 | 4.83 |
| 2020-12-31 | 2.68 |
| 2020-09-30 | 0.32 |
| 2020-06-30 | 1.28 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.56 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
